How a drug company under pressure for high prices ratchets up political activity

How a drug company under pressure for high prices ratchets up political activity

Source: 
Stat
snippet: 

Business looked challenging for Novo Nordisk at the end of 2016. As pressure mounted over the pharma giant’s soaring insulin prices, investors drove its stock down by a third on fears that policymakers would take action, limit prices and hurt profits.